Wall Street indexes slip with interest rates, Middle East in focus

U.S. stock indexes fell on Monday while Treasury yields rose, as traders tamped down bets for Federal Reserve interest-rate easing.

Uncertainty around the Middle East conflict added to worries ahead of quarterly earnings season and fresh economic data.

After Friday’s stronger-than-expected jobs report, traders pulled back from bets for a 50-basis-point rate cut in November. They were pricing in an 86% chance of a 25-basis-point cut and a roughly 14% chance the central bank would not cut rates at all, according to the CME’s FedWatch tool.

The change in rate-cut expectations caused U.S. Treasury yields to rally, with the yield on benchmark 10-year notes exceeding 4% for the first time in two months.

Besides next month’s Fed meeting, investors are waiting for the Consumer Price Index inflation reading for September and the kickoff of third-quarter earnings season with reports from banks, both due this week.

“We think this is short-term nervousness that will be healed over the next five days when the CPI number is released and the bank earnings,” said James Demmert, chief investment officer at Main Street Research.
Demmert noted the intensifying Middle East conflict as a concern for U.S. investors who are worried about the war’s economic impact, including rising oil prices.
Investors continue to fret about how Israel would respond to Iran’s missile strikes. On Monday, Lebanon’s armed group Hezbollah fired rockets at Israel’s city of Haifa while Israeli forces looked poised to expand ground raids into south Lebanon.
On Wall Street at 2:29 p.m. ET, the Dow Jones Industrial Average fell 347.82 points, or 0.82%, to 42,004.93, the S&P 500 fell 34.11 points, or 0.59%, to 5,717.01 and the Nasdaq Composite fell 102.95 points, or 0.56%, to 18,035.60.

Among the S&P 500’s 11 major industry indexes, only energy advanced, rising 0.5%. U.S. crude futures rose for the fifth-straight session on concerns about Middle East supply disruptions.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Must Read

Moderna reports surprise profit on higher-than-expected COVID vaccine sales

Moderna reported a surprise third-quarter profit on Thursday, driven by cost cutting and higher-than-expected sales of its COVID-19 vaccine, even with low revenue from its...